Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial is a PHASE2 clinical asset sponsored by Dallas VA Medical Center in Amyotrophic Lateral Sclerosis (ALS). SEO and diligence focus: Antioxidants, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.